Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Introduction of Probiotic Type of Yogurt for the Treatment of Dysbiosis of Patients with Lymphogranulomatosis Under Polychemotherapy by BEACOPP‑II Protocol


Affiliations
1 Associate Professor, Department of Internal Medicine No.2, Federal University, Simferopol, Russian Federation
2 Assistant Professor, Department of Internal Medicine No.1,, Russian Federation
3 Professor, Department of Dentistry and Orthodontics, Russian Federation
4 Associate Professor, Department of Psychiatry, Narcology, Psychotherapy with a Course of General and Medical Psychology, Federal University, Simferopol, Russian Federation
5 Associate Professor, Department of Internal Medicine No.1, Federal University, Simferopol, Russian Federation
6 Department of Internal Medicine No.2, V.I. Vernadsky Crimean Federal University, Simferopol, Russian Federation
     

   Subscribe/Renew Journal


The efficacy of using probiotic preparations of the yogurt type was studied in 136 patients with lymphogranulomatosis, suffering from intestinal dysbiosis while taking antibiotic therapy and polychemotherapy (BEACOPP-II protocol). It was found that probiotics of this type are highly effective for the treatment of dysbiotic disorders of the intestines in cancer and hematological patients. Their use significantly reduces the risk of complications such as an unpleasant aftertaste in the mouth, belching, heartburn, diarrhea, constipation, flatulence, discomfort or periodic abdominal pain. It is recommended that prolonged therapy with a probiotic of the yogurt type be used in these groups of patients.

Keywords

Probiotic, dysbiosis, eubiosis, dyspepsia, lymphogranulomatosis, polychemotherapy
Subscription Login to verify subscription
User
Notifications
Font Size


Abstract Views: 219

PDF Views: 0




  • Introduction of Probiotic Type of Yogurt for the Treatment of Dysbiosis of Patients with Lymphogranulomatosis Under Polychemotherapy by BEACOPP‑II Protocol

Abstract Views: 219  |  PDF Views: 0

Authors

V. B. Kaliberdenko
Associate Professor, Department of Internal Medicine No.2, Federal University, Simferopol, Russian Federation
E. S. Kuznetsov
Assistant Professor, Department of Internal Medicine No.1,, Russian Federation
M. N. Morozova
Professor, Department of Dentistry and Orthodontics, Russian Federation
A. L. Malev
Associate Professor, Department of Psychiatry, Narcology, Psychotherapy with a Course of General and Medical Psychology, Federal University, Simferopol, Russian Federation
A. N. Zakharova
Associate Professor, Department of Internal Medicine No.1, Federal University, Simferopol, Russian Federation
K. Shanmugaraj
Department of Internal Medicine No.2, V.I. Vernadsky Crimean Federal University, Simferopol, Russian Federation
K. Balasundaram
Department of Internal Medicine No.2, V.I. Vernadsky Crimean Federal University, Simferopol, Russian Federation

Abstract


The efficacy of using probiotic preparations of the yogurt type was studied in 136 patients with lymphogranulomatosis, suffering from intestinal dysbiosis while taking antibiotic therapy and polychemotherapy (BEACOPP-II protocol). It was found that probiotics of this type are highly effective for the treatment of dysbiotic disorders of the intestines in cancer and hematological patients. Their use significantly reduces the risk of complications such as an unpleasant aftertaste in the mouth, belching, heartburn, diarrhea, constipation, flatulence, discomfort or periodic abdominal pain. It is recommended that prolonged therapy with a probiotic of the yogurt type be used in these groups of patients.

Keywords


Probiotic, dysbiosis, eubiosis, dyspepsia, lymphogranulomatosis, polychemotherapy



DOI: https://doi.org/10.37506/v11%2Fi2%2F2020%2Fijphrd%2F194995